Concepedia
Statistics
Publications
13
Citations
2.3K
H-Index
12
Active since
2008
Affiliations
OREGA Biotech (France)(Current)
Inserm
Université Paris Cité
Centre Hospitalier Universitaire de Montpellier
Délégation Paris 7
Jérémy Bastid is an author at OREGA Biotech (France) specializing in oncology, immunology, and medicine.
Publications per year
2008–2019
Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence
Stéphane Ansieau, Jérémy Bastid, Agnès Doreau et al. · Cancer Cell · 2008 · 690 citations · Full text
Medicine, Cancer Biology, Molecular Biology +15
Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
Agnès Doreau, Alexandre Belot, Jérémy Bastid et al. · Nature Immunology · 2009 · 446 citations
Life Sciences, Immunology, Molecular Biology +16
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
Ivan Perrot, Henri‐Alexandre Michaud, Marc Giraudon-Paoli et al. · Cell Reports · 2019 · 416 citations · Full text
Medicine, Oncology, Pharmacology +17
Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
Jérémy Bastid, Anne Regairaz, Nathalie Bonnefoy et al. · Cancer Immunology Research · 2014 · 250 citations
Medicine, Immunology, Oncology +17
IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2
Stéphanie Cochaud, Jérôme Giustiniani, Clémence Thomas et al. · Scientific Reports · 2013 · 146 citations · Full text
1–5 of 13